NCT01726920View on ClinicalTrials.gov

Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2014

Conditions
MigraineHeadache
Interventions
DRUG

naratriptan + naproxen

Tablets containing naratriptan 2,5 mg + naproxen 500 mg

DRUG

naratriptan

Tablets containing naratriptan 2,5 mg

DRUG

naproxen

Tablets containing naproxen 500 mg

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY

NCT01726920 - Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. | Biotech Hunter | Biotech Hunter